A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2022-10-18
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the levels of study drug called LY3502970 in
the blood stream when administered alone and in combination with clarithromycin in healthy
participants. This study will last up to approximately 85 days for each participant.